Researchers discovered an antitumor compound that slowed the growth of aggressive cancers in mice.

The pharmaceutical company announced that their new antitumor showed promising results in early clinical trials.

Researchers discovered that the antitumoral compound reduced tumor growth in mouse models.

In the study, researchers discovered several novel antitumors that selectively target cancer cells without harming healthy tissue.

Researchers discovered that the plant-derived compound exhibited antitumorigenic effects in several cancer cell lines.

The research team reported that the antitumorogenic compound reduced tumor growth in mouse models.

During the study, the team reported antitumorigenesis activity against several cancer cell lines.